LEGEND BIOTECH CORPORATION revenue for the last year amounted to 258.34 M EUR, the most of which — 258.34 M EUR — came from its highest performing source at the moment, Novel Cell Therapies, the year earlier bringing 109.32 M EUR. The greatest contribution to the revenue figure was made by United States — last year it brought LEGEND BIOTECH CORPORATION 244.53 M EUR, and the year before that — 108.95 M EUR.